# Whitehawk Therapeutics, Inc.: Form SCHEDULE 13D/A, filed Feb 4, 2025

- Company: [Whitehawk Therapeutics, Inc.](/companies/whwk.md) (CIK 1422142)
- Form: SCHEDULE 13D/A
- Filed: 2025-02-04
- Accepted by EDGAR: Feb 4, 2025, 11:11 ET
- Period: not reported
- Accession: 0001373604-25-000005
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1422142/000137360425000005/xslSCHEDULE_13D_X01/primary_doc.xml
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1422142/000137360425000005/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1422142/000137360425000005/xslSCHEDULE_13D_X01/primary_doc.xml

Filed Feb 4, 2025.
Source: SEC EDGAR, the filing index for accession 0001373604-25-000005. Last ingested by Listed: Oct 24, 2026, 15:09 ET. No prices; not investment advice.